Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR) Listen to this Section


$8.89
-0.1100 ( -1.22% ) 0.0K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$8.89

Previous close


$9.00

Volume


0.0K

Market cap


$43.53M

Day range


$8.61 - $9.00

52 week range


$7.11 - $10.04

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 01, 2023
8-k 8K-related 13 Nov 28, 2023
4 Insider transactions 1 Nov 27, 2023
nport-p Other 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 13, 2023
4 Insider transactions 1 Nov 02, 2023
8-k 8K-related 12 Oct 27, 2023
4 Insider transactions 1 Oct 16, 2023
4 Insider transactions 1 Sep 20, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.